F7
F7 (coagulation factor VII) is a vitamin K-dependent serine protease that initiates the extrinsic pathway of blood coagulation. It circulates in the blood as a zymogen and, once activated to factor VIIa, drives the coagulation cascade in the presence of tissue factor and calcium ions. Browse Assay Genie's current range of F7 research reagents below, or read on for the biology behind the target.
F7 is a serine protease that initiates the extrinsic pathway of blood coagulation. It circulates in the blood in a zymogen form and is converted to factor VIIa by minor proteolysis, carried out by factor Xa, factor XIIa, factor IXa or thrombin. In the presence of tissue factor (factor III) and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. It also converts factor IX to factor IXa under the same conditions, so further activating the coagulation cascade.
Activation generates two chains: a heavy chain that contains the catalytic domain and a light chain that contains two EGF-like domains. A disulfide bond holds the chains together. The protein is secreted and belongs to the peptidase S1 family. HGNC places it in the groups of serine proteases, Gla domain containing proteins and coagulation factors, and it is described as a vitamin K-dependent factor essential for haemostasis. The human F7 gene has mouse and rat orthologs, both also named F7. Alternative splicing of the F7 gene gives multiple transcript variants that encode different isoforms, which may undergo similar proteolytic processing to produce mature polypeptides.
The protein was formerly named coagulation factor VII (serum prothrombin conversion accelerator). Defects in the F7 gene can cause coagulopathy, so factor VII is widely studied in haemostasis and bleeding disorder research. Researchers working on the F7 protein often examine zymogen activation, tissue factor-dependent signalling in the cascade and the roles of factor VIIa in activating factors IX and X.
F7 is a vitamin K-dependent factor essential for haemostasis, making it a core component in studies of blood clotting.
Factor VIIa with tissue factor and calcium ions initiates the extrinsic pathway by converting factor X to factor Xa.
Factor VII is activated by factor Xa, factor XIIa, factor IXa or thrombin through minor proteolysis, a useful model of protease cascades.
Defects in the F7 gene can cause coagulopathy, so the protein is relevant to research on inherited bleeding disorders.
F7 encodes coagulation factor VII, a secreted serine protease that initiates the extrinsic pathway of blood coagulation. After activation to factor VIIa, it converts factor X to factor Xa and factor IX to factor IXa in the presence of tissue factor and calcium ions.
Factor VII circulates as a zymogen. Factor IXa, factor Xa, factor XIIa or thrombin cleaves it by minor proteolysis into a heavy chain and a light chain joined by a disulfide bond. Alternative splicing of F7 produces multiple transcript variants encoding different isoforms.
Mouse and rat both have an ortholog named F7. In humans, defects in the F7 gene can cause coagulopathy. When choosing reagents for cross-species work, check the datasheet of any product for its validated reactivity.
Coagulation factors, tissue factor and other proteases in the clotting cascade that act alongside F7.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P08709; product specifications from Assay Genie datasheets.